Abstract
Since systemic lupus erythematosus (SLE) is an autoimmune disease that primarily affects women during their reproductive years, pregnancy is a frequently encountered challenge in women with this disorder. In the past, women with SLE were advised to avoid pregnancy because of the fear of harm to the fetus and mother. Fortunately, due to the advances in the management of lupus during pregnancy over the last few decades, many SLE pregnancies have successful maternal and fetal outcomes.
Fertility rates in women with SLE are similar to that of the general population. Studies comparing women with SLE to healthy controls show a similar mean number of pregnancies, between 2.15 and 3.6 (Petri and Allbritton, J Rheumatol. 1993;20(4):650–6). Annually there are about 4,500 pregnancies in women with SLE in the USA (Clowse et al. Am J Obstet Gynecol. 2008;199(2):127 e1–6). The majority will experience no more than mild SLE activity involving the joints and cutaneous disease during pregnancy (Clowse, Rheum Dis Clin North Am. 2007;33(2):237–52). However, for a small number, SLE activity will adversely affect their pregnancies leading to severe SLE exacerbations with organ involvement that may affect long-term maternal survival, or development of preeclampsia, low birth weight, preterm delivery, and/or pregnancy loss. We currently have ways to mitigate this risk by maintaining low SLE activity, choosing appropriate pregnancy timing, monitoring SLE activity by a multidisciplinary team composed of both an obstetrician and a rheumatologist and prompt treatment of any flares. This enables many women with SLE to achieve the delivery of a healthy infant.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clowse ME. Lupus activity in pregnancy. Rheum Dis Clin North Am. 2007;33(2):237–52.
Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol. 1993;20(4):650–6.
Georgiou PE, Politi EN, Katsimbri P, Sakka V, Drosos AA. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford). 2000;39(9):1014–9.
Clark CA, Spitzer KA, Nadler JN, Laskin CA. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol. 2003;30(10):2127–32.
Carmona F, Font J, Cervera R, Munoz F, Cararach V, Balasch J. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol. 1999;83(2):137–42.
Varner MW, Meehan RT, Syrop CH, Strottmann MP, Goplerud CP. Pregnancy in patients with systemic lupus erythematosus. Am J Obstet Gynecol. 1983;145(8):1025–40.
Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514–21.
Lima F, Buchanan NM, Khamashta MA, Kerslake S, Hughes GR. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum. 1995;25(3):184–92.
Clowse ME, Magder LS, Witter F, Petri M. Early risk factors for pregnancy loss in lupus. Obstet Gynecol. 2006;107(2 Pt 1):293–9.
Yasmeen S, Wilkins EE, Field NT, Sheikh RA, Gilbert WM. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med. 2001;10(2):91–6.
Wong KL, Chan FY, Lee CP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med. 1991;151(2):269–73.
Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996;35(2):133–8.
Rubbert A, Pirner K, Wildt L, Kalden JR, Manger B. Pregnancy course and complications in patients with systemic lupus erythematosus. Am J Reprod Immunol. 1992;28(3–4):205–7.
Chakravarty EF, Colon I, Langen ES, Nix DA, El-Sayed YY, Genovese MC, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192(6):1897–904.
Johnson MJ, Petri M, Witter FR, Repke JT. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol. 1995;86(3):396–9.
Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002;41(6):643–50.
Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience. Arthritis Rheum. 1991;34(12):1538–45.
Petri M, Howard D, Repke J, Goldman DW. The Hopkins Lupus Pregnancy Center: 1987–1991 update. Am J Reprod Immunol. 1992;28(3–4):188–91.
Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM, Huong DL, Denjoy I, Vauthier D, et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum. 2004;50(10):3187–94.
Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation. 2012;126(1): 76–82.
Schroeder BM. ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. Am Fam Physician. 2002;66(2):330–1.
Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199(2):127 e1–6.
Petri M. Hopkins lupus pregnancy center: 1987 to 1996. Rheum Dis Clin North Am. 1997;23(1):1–13.
Abramson SB, Buyon JP. Activation of the complement pathway: comparison of normal pregnancy, preeclampsia, and systemic lupus erythematosus during pregnancy. Am J Reprod Immunol. 1992;28(3–4):183–7.
Denny KJ, Woodruff TM, Taylor SM, Callaway LK. Complement in pregnancy: a delicate balance. Am J Reprod Immunol. 2013;69(1):3–11.
Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess. 2008;12(6):iii-iv, 1–270.
Laresgoiti-Servitje E, Gomez-Lopez N. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibody-mediated mechanisms. Biol Reprod. 2012;87(2):36.
Ji L, Brkic J, Liu M, Fu G, Peng C, Wang YL. Placental trophoblast cell differentiation: physiological regulation and pathological relevance to preeclampsia. Mol Aspects Med. 2012;34(5): 981–1023.
Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;2:CD004659.
Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet. 2005;271(3):222–6.
Tincani A, Bazzani C, Zingarelli S, Lojacono A. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. Semin Thromb Hemost. 2008;34(3):267–73.
Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum. 1993;36(10):1392–7.
Tincani A, Faden D, Tarantini M, Lojacono A, Tanzi P, Gastaldi A, et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol. 1992;10(5):439–46.
Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–7.
Levy RA, Vilela VS, Cataldo MJ, Ramos RC, Duarte JL, Tura BR, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10(6): 401–4.
Motta M, Tincani A, Faden D, Zinzini E, Lojacono A, Marchesi A, et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol. 2005;25(2):86–9.
Ostensen M, Lockshin M, Doria A, Valesini G, Meroni P, Gordon C, et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford). 2008;47 Suppl 3:iii28–31.
Julkunen H. Pregnancy and lupus nephritis. Scand J Urol Nephrol. 2001;35(4):319–27.
Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus. 2005;14(1):89–94.
Wagner SJ, Craici I, Reed D, Norby S, Bailey K, Wiste HJ, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18(4):342–7.
Saavedra MA, Cruz-Reyes C, Vera-Lastra O, Romero GT, Cruz-Cruz P, Arias-Flores R, et al. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol. 2012;31(5):813–9.
Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38(9):1906–13.
Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010;5(11):2060–8.
Liu S, Rouleau J, Joseph KS, Sauve R, Liston RM, Young D, et al. Epidemiology of pregnancy-associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Can. 2009;31(7):611–20.
Gezer S. Antiphospholipid syndrome. Disease-A-Month: DM. 2003;49(12):696–741.
Mok CC, Tang SS, To CH, Petri M. Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups. Arthritis Rheum. 2005;52(9): 2774–82.
Gladman DD, Tandon A, Ibanez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol. 2010;37(4):754–8.
Wolfberg AJ, Lee-Parritz A, Peller AJ, Lieberman ES. Association of rheumatologic disease with preeclampsia. Obstet Gynecol. 2004;103(6):1190–3.
Yan Yuen S, Krizova A, Ouimet JM, Pope JE. Pregnancy outcome in systemic lupus erythematosus (SLE) is improving: results from a case control study and literature review. Open Rheumatol J. 2008;2:89–98.
Tunks RD, Clowse ME, Miller SG, Brancazio LR, Barker PC. Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am J Obstet Gynecol. 2013;208(1):64 e1–7.
Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62(6):385–92.
Armenti VT, Daller JA, Constantinescu S, Silva P, Radomski JS, Moritz MJ, et al. Report from the national transplantation pregnancy registry: outcomes of pregnancy after transplantation. Clin Transpl. 2006;57–70. PubMed PMID: 18368705. Epub 2008/03/28. eng.
Hussein MM, Mooij JM, Roujouleh H. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol. 1993;40(3):160–3.
Doria A, Di Lenardo L, Vario S, Calligaro A, Vaccaro E, Gambari PF. Cyclosporin A in a pregnant patient affected with systemic lupus erythematosus. Rheumatol Int. 1992;12(2):77–8.
Auyeung-Kim DJ, Devalaraja MN, Migone TS, Cai W, Chellman GJ. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reprod Toxicol. 2009;28(4):443–55.
GlaxoSmithKline. Use of Intravenous (IV) Benlysta in Pregnant Patients with Systemic Lupus Erythematosus (SLE) 2013.
Rauova L, Lukac J, Levy Y, Rovensky J, Shoenfeld Y. High-dose intravenous immunoglobulins for lupus nephriti— salvage immunomodulation. Lupus. 2001;10(3):209–13.
Perricone R, De Carolis C, Kroegler B, Greco E, Giacomelli R, Cipriani P, et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford). 2008;47(5):646–51.
Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14(8):593–7.
Gwyn KM, Theriault RL. Breast cancer during pregnancy. Curr Treat Options Oncol. 2000;1(3):239–43.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wasserman, S., Clowse, M.E.B. (2014). Systemic Lupus Erthematosus. In: Sammaritano, L., Bermas, B. (eds) Contraception and Pregnancy in Patients with Rheumatic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0673-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0673-4_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0672-7
Online ISBN: 978-1-4939-0673-4
eBook Packages: MedicineMedicine (R0)